Zobrazeno 1 - 10
of 19
pro vyhledávání: '"William E. Hobbs"'
Autor:
David R. Light, Sharada A. Sarnaik, Moira M. Lancelot, Nancy Moore, Dipti Gupta, Patrick C. Hines, William E. Hobbs, Jennell White, Sriram Krishnamoorthy
Publikováno v:
British Journal of Haematology. 174:970-982
Summary Very Late Antigen-4 (VLA-4, α4β1-integrin, ITGA4) orchestrates cell-cell and cell-endothelium adhesion. Given the proposed role of VLA-4 in sickle cell disease (SCD) pathophysiology, we evaluated the ability of the VLA-4 blocking antibody n
Autor:
Benjamin Vieira, Julia E. Brittain, Sarah Sturtevant, Sriram Krishnamoorthy, Dipti Gupta, Timothy Thullen, Levi Makala, Huo Li, Biaoru Li, David R. Light, Betty S. Pace, Ivan Stone, Nancy Moore, William E. Hobbs
Publikováno v:
JCI insight. 2(20)
Sickle cell disease (SCD) results from a point mutation in the β-globin gene forming hemoglobin S (HbS), which polymerizes in deoxygenated erythrocytes, triggering recurrent painful vaso-occlusive crises and chronic hemolytic anemia. Reactivation of
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 33:1230-1237
Objective— Cocaine use is associated with arterial thrombosis, including myocardial infarction and stroke. Cocaine use results in increased plasma von Willebrand factor (VWF), accelerated atherosclerosis, and platelet-rich arterial thrombi, suggest
Publikováno v:
Journal of Virology. 76:2180-2191
The herpes simplex virus type 1 (HSV-1) mutantd109 does not express any of the immediate-early (IE) proteins and persists in cells for a prolonged length of time. As has been shown by Nicholl et al. (J. Gen. Virol. 81:2215-2218, 2000) and Mossman et
Autor:
Gersham Dent, William E. Hobbs, Nicolas Currier, Jacobus Burggraaf, Jaladhar Neelavalli, Paul Swerdlow, Brijesh Kumar Yadav, Ajay Verma, W. Birkhoff, Muhammad Shahid, Jaspert de Vries
Publikováno v:
Blood. 128:4871-4871
Background: Vascular complications such as stroke and pulmonary hypertension are central features of sickle cell disease (SCD) pathophysiology and are associated with early mortality among patients with SCD. Better understanding of the abnormal blood
Autor:
Robert T. Peters, William E. Hobbs, Sarah Sturtevant, Benjamin Vieira, Dipti Gupta, Yukio Nakamura, Betty S. Pace, David R. Light, Christine Loh, Sriram Krishnamoorthy, Brian Lucas
Publikováno v:
Blood. 128:4840-4840
Sickle Cell Disease (SCD) is caused by a point mutation in the beta- chain of hemoglobin, triggering a complex pathophysiology resulting in recurrent, painful vaso-occlusive events (VOCs) and chronic hemolytic anemia. Induction of fetal hemoglobin (H
Autor:
William E. Hobbs, Neal A. DeLuca
Publikováno v:
Journal of Virology. 73:8245-8255
Herpes simplex virus type 1 is capable of inhibiting host cell DNA synthesis following lytic infection. However, the mechanism and nature of potential effects on cell cycle progression have not been described. In this report, we characterize the dysr
Publikováno v:
Blood. 126:2057-2057
Central venous access devices (CVADs), such as tunneled central venous catheters (tCVADs) and peripherally inserted central catheters (PICCs), help provide essential care for some patients with sickle cell disease (SCD). CVADs facilitate administrati
Autor:
Betty S. Pace, David R. Light, Sriram Krishnamoorthy, William E. Hobbs, Dipti Gupta, Sarah Sturtevant, Biaoru Li, Levi C Makala
Publikováno v:
Blood. 126:410-410
Sickle cell disease (SCD) is caused by a point mutation in the β-chain of hemoglobin, which triggers a complex pathophysiology resulting in recurrent, painful vaso-occlusive crises (VOC) and chronic hemolytic anemia. Fetal hemoglobin (HbF) is the ma
Publikováno v:
Blood. 126:3278-3278
Beta(β)-thalassemia is a rare disease, with limited data available on the typical clinical course and outcomes of patients in the US. There are currently no nationwide surveillance efforts to monitor the prevalence or changes in outcomes among those